X @Forbes
Forbesยท2025-07-31 12:44
Company Overview - A 60-year-old drug developer built a $4.4 billion biotech company [1] - The company focuses on treating 'Butterfly Skin Disease' (Epidermolysis Bullosa) [1]
Company Overview - A 60-year-old drug developer built a $4.4 billion biotech company [1] - The company focuses on treating 'Butterfly Skin Disease' (Epidermolysis Bullosa) [1]